missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human FGF-23 ELISA Kit
Click to view available options
Menge:
10 x 96 Tests
5 x 96 Tests
96 Tests
Packungsgröße:
1 Stück
10 Stück
96 Stück
Beschreibung
Human FGF-23 quantitates human FGF-23 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human FGF-23.
The protein encoded by this gene is a member of the fibroblast growth factor family. FGF family members possess broad mitogenic and cell survival activities and are involved in a variety of biological processes including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. The product of this gene inhibits renal tubular phosphate transport. This gene was identified by its mutations associated with autosomal dominant hypophosphatemic rickets, an inherited phosphate wasting disorder. Abnormally high level expression of this gene was found in oncogenic hypophosphatemic osteomalacia, a phenotypically similar disease caused by abnormal phosphate metabolism. Mutations in this gene have also been shown to cause familial tumoral calcinosis with hyperphosphatemia.
Spezifikation
Spezifikation
| Zugriffsnummer | ADHR; FGF; Fgf23; FGF-23; FGFN; Fibroblast growth factor; Fibroblast growth factor 23; Fibroblast growth factor 23 C-terminal peptide; Fibroblast growth factor 23 N-terminal peptide; HPDR2; HYPF; Phosphatonin; PHPTC; tumor-derived hypophosphatemia inducing factor; Tumor-derived hypophosphatemia-inducing factor; UNQ3027/PRO9828 |
| Assay-Bereich | 0,3 bis 75 ng/ml |
| Assay-Empfindlichkeit: | 0.3 ng/mL |
| Konjugat | Biotin |
| Produkttyp | ELISA |
| Probentyp | Serum, Supernatant |
| Zur Verwendung mit (Geräte) | Kolorimetrisches Mikrotiterplatten-Lesegerät |
| Gen-ID (Entrez) | 8074 |
| Gensymbol | FGF23 |
| Interassay-VK | <12% |
| Mehr anzeigen |
Berichtigung von Produktinhalten
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.
Name des Produkts
Haben Sie Verbesserungsvorschläge?Übermitteln Sie eine inhaltliche Korrektur